Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance.

[1]  G. Hommel,et al.  Immunohistochemical study on the prognostic value of MIB-1 in gastric carcinoma. , 1996, British Journal of Cancer.

[2]  T. Powles,et al.  Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinomas. , 1996, British Journal of Cancer.

[3]  T. Nagao,et al.  Determination of S-phase cells by in situ hybridization for histone H3 mRNA in hepatocellular carcinoma: correlation with histologic grade and other cell proliferative markers. , 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[4]  T. Matsumata,et al.  Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen , 1995, Cancer.

[5]  S. Watanabe.  [Assessment of the proliferative activity of hepatocellular carcinoma with the monoclonal antibody Ki-67 using flow cytometry]. , 1995, Nihon Geka Gakkai zasshi.

[6]  W. Weikel,et al.  Usefulness of immunohistochemical staining for p53 in the prognosis of breast carcinomas: correlations with established prognosis parameters and with the proliferation marker, MIB-1. , 1995, Gynecologic oncology.

[7]  F. Kondo,et al.  Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining. , 1995, Human pathology.

[8]  R. Cote,et al.  Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. , 1995, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  T. Oyama,et al.  Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. , 1995, Human pathology.

[10]  I. Ellis,et al.  Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival. , 1995, British Journal of Cancer.

[11]  D. Chopin,et al.  Usefulness of MIB1 monoclonal antibody in assessing the proliferative index in human bladder carcinoma: comparison with Ki‐67 antibody , 1994, Histopathology.

[12]  T. Visakorpi,et al.  Prognostication of astrocytoma patient survival by Ki‐67 (MIB‐1), PCNA, and S‐phase fraction using archival paraffin‐embedded samples , 1994, The Journal of pathology.

[13]  J. Cheville,et al.  Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[14]  R. Bast,et al.  Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis. , 1994, American journal of clinical pathology.

[15]  G. Palestro,et al.  MIB-1, Ki67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. , 1994, Journal of clinical pathology.

[16]  C. V. Howard,et al.  Analysis of relative proliferation rates of Wilms' tumor components using proliferating cell nuclear antigen and MIB-1 (Ki-67 equivalent antigen) immunostaining and assessment of mitotic index. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[17]  Johannes Gerdes,et al.  Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections , 1992, The Journal of pathology.

[18]  H Stein,et al.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. , 1984, Journal of immunology.